The story of the rise and fall of the once multi-billion dollar health care company Theranos, Inc. (“Theranos”) and its founder, Elizabeth Holmes, no longer serves merely as a bingeworthy weekend watch but rather yet another cautionary tale for corporations and their counsel. In 2015, Holmes touted a $9-billion dollar valuation of Theranos after... READ MORE
Theranos Ruling Serves as an Important Reminder of the Limits of the Attorney-Client Privilege and Individual Accountability in Corporate Wrongdoing
Posted on July 7, 2021 in Health Law News
Published by: Hall Render
